✦ LIBER ✦

W1011 Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Silymarin (SM) Following Chronic Dosing in Patients with Chronic Hepatitis C (HCV)

✍ Scribed by Schrieber, Sarah J.; Soule, Tedi A.; Wen, Zhiming; Wahed, Abdus S.; Smith, Philip C.; Fried, Michael W.; Reddy, K. Rajender; Navarro, Victor J.; Afdhal, Nezam; Belle, Steven H.; Berman, Josh; Liu, Q.; Doo, Edward; Hawke, Roy L.

Book ID: 122352883
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 132 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63887-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

313 A 1/2phase study to evaluate the pha

313 A 1/2phase study to evaluate the pharmacokinetics, safety, tolerability, immunogenicity, and pharmacodynamics of albuferon™ in the treatment experienced subjects with chronic hepatitis C

✍ V. Balan; M. Sulkowski; D. Nelson; G. Everson; T. Bambury; J. Recta; J. Zhong; H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

A phase 2 study to evaluate the antivira

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

✍ Vincent G. Bain; Kelly D. Kaita; Eric M. Yoshida; Mark G. Swain; E. Jenny Heathc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Phase-I/II study to evaluate dose limiti

Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

✍ T. Lissitchkov; G. Arnaudov; D. Peytchev; Kh. Merkle 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 183 KB